Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fluconazole--a new antifungal agent].

J H Dobloug1

  • 1Infeksjonsmedisinsk avdeling, Ullevål sykehus, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|June 10, 1992
PubMed
Summary

Fluconazole is a new antifungal drug with a favorable pharmacokinetic profile, effective against various fungi. It is administered once daily and shows good tissue penetration, including in cerebrospinal fluid.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment.

AIDS (London, England)·1995
Same author

[Norwegian infection control in the new Europe].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1994
Same author

Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations.

The Journal of infectious diseases·1994
Same author

[Norwegian infection control in modern Europe].

Nordisk medicin·1994
Same author

[Systemic mycoses. Epidemiology, clinical aspects, diagnosis].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1992
Same author

[Post-splenectomy septicemia].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·1990

Area of Science:

  • Pharmacology
  • Mycology

Context:

  • Fluconazole represents a significant advancement in antifungal therapy.
  • Its pharmacokinetic profile influences dosing and efficacy.

Purpose:

  • To evaluate the efficacy and pharmacokinetic properties of fluconazole.
  • To outline appropriate clinical applications and contraindications.

Summary:

  • Fluconazole, a triazole antifungal, demonstrates broad-spectrum activity against fungi.
  • It is orally absorbed irrespective of food, with a once-daily dosage (50-400 mg).
  • Good tissue penetration, including cerebrospinal fluid, is observed.

Impact:

  • Fluconazole offers a convenient dosing regimen and effective treatment for various fungal infections.
  • Established contraindications include use in individuals under 16, pregnant, or breastfeeding women.

Related Experiment Videos